Qishenyiqi Protects Ligation-Induced Left Ventricular Remodeling by Attenuating Inflammation and Fibrosis via STAT3 and NF-κB Signaling Pathway

AIM: Qi-shen-yi-qi (QSYQ), a formula used for the routine treatment of heart failure (HF) in China, has been demonstrated to improve cardiac function through down-regulating the activation of the Renin-Angiotensin-Aldosterone System (RAAS). However, the mechanisms governing its therapeutic effects a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chun, Wang, Yong, Qiu, Qi, Shi, Tianjiao, Wu, Yan, Han, Jing, Chai, Xingyun, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133204/
https://www.ncbi.nlm.nih.gov/pubmed/25122164
http://dx.doi.org/10.1371/journal.pone.0104255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133204/
https://www.ncbi.nlm.nih.gov/pubmed/25122164
http://dx.doi.org/10.1371/journal.pone.0104255

Ejemplares similares